Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(23):1870; doi:10.1093/jnci/92.23.1870
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 23, 1870, December 6, 2000
© 2000 Oxford University Press

NEWS

Consensus Panel Endorses Range of Adjuvant Therapies For Breast Cancer

Caroline McNeil

Treatment with a combination of chemotherapy drugs improves survival and should be recommended for most women with local and regional breast cancer, according to the statement emerging from the Consensus Development Conference on Adjuvant Therapy for Breast Cancer, held Nov. 1–3 at the National Institutes of Health in Bethesda, Md.

The consensus panel also recommended hormonal therapy for women whose tumors have hormone . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?